Essential roles of bile acid receptors FXR and TGR5 as metabolic regulators

References

• Chiang JY. 2002. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev. 23:443–463.10.1210/er.2000-0035
   PubMed Web of Science ®Google Scholar
• Cipriani S, Mencarelli A, Chini MG, Distrutti E, Renga B, Bifulco G, Baldelli F, Donini A, Fiorucci S. 2011. The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PloS One. 6:e25637.10.1371/journal.pone.0025637.s005
   PubMed Web of Science ®Google Scholar
• Claudel T, Staels B, Kuipers F. 2005. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol. 25:2020–2030.10.1161/01.ATV.0000178994.21828.a7
   PubMed Web of Science ®Google Scholar
• Duboc H, Taché Y, Hofmann AF. 2014. The bile acid TGR5 membrane receptor: from basic research to clinical application. Dig Liver Dis. 46:302–312.10.1016/j.dld.2013.10.021
   PubMedGoogle Scholar
• Dufer M, Hörth K, Krippeit-Drews P, Drews G. 2012. The significance of the nuclear farnesoid X receptor (FXR) in beta cell function. Islets. 4:333–338.10.4161/isl.22383
   PubMed Web of Science ®Google Scholar
• Dufer M, Horth K, Wagner R, Schittenhelm B, Prowald S, Wagner TF, Oberwinkler J, Lukowski R, Gonzalez FJ, Krippeit-Drews P, et al. 2012. Bile acids acutely stimulate insulin secretion of mouse beta-cells via farnesoid X receptor activation and K(ATP) channel inhibition. Diabetes. 61:1479–1489.10.2337/db11-0815
   PubMed Web of Science ®Google Scholar
• Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, van Dijk TH, Gonzalez FJ, Fruchart JC, Kuipers F, Staels B. 2005. The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J Biol Chem. 280:29971–29979.10.1074/jbc.M501931200
   PubMed Web of Science ®Google Scholar
• Edwards PA, Kast HR, Anisfeld AM. 2002. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res. 43:2–12.
   PubMed Web of Science ®Google Scholar
• Fan M, Wang X, Xu G, Yan Q, Huang W. 2014. Bile acid signaling and liver regeneration. Biochim Biophys Acta. pii:S1874–9399. [Epub ahead of print].
   Google Scholar
• Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, et al. 1995. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell. 81:687–693.10.1016/0092-8674(95)90530-8
   PubMed Web of Science ®Google Scholar
• Gerhard GS, Styer AM, Wood GC, Roesch SL, Petrick AT, Gabrielsen J, Strodel WE, Still CD, Argyropoulos G. 2013. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass. Diabetes Care. 36:1859–1864.10.2337/dc12-2255
   PubMed Web of Science ®Google Scholar
• Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, Dong B, Huang X, Moore DD. 2006. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science. 312:233–236.10.1126/science.1121435
   PubMed Web of Science ®Google Scholar
• Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, et al. 2005. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2:217–225.10.1016/j.cmet.2005.09.001
   PubMed Web of Science ®Google Scholar
• Inagaki T, Moschetta A, Lee YK, Peng L, Zhao G, Downes M, Yu RT, Shelton JM, Richardson JA, Repa JJ, et al. 2006. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci USA. 103:3920–3925.10.1073/pnas.0509592103
   PubMed Web of Science ®Google Scholar
• Jiang T, Wang XX, Scherzer P, Wilson P, Tallman J, Takahashi H, Li J, Iwahashi M, Sutherland E, Arend L, et al. 2007. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy. Diabetes. 56:2485–2493.10.2337/db06-1642
   PubMed Web of Science ®Google Scholar
• Katsuma S, Hirasawa A, Tsujimoto G. 2005. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun. 329:386–390.10.1016/j.bbrc.2005.01.139
   PubMed Web of Science ®Google Scholar
• Keitel V, Donner M, Winandy S, Kubitz R, Häussinger D. 2008. Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun. 372:78–84.10.1016/j.bbrc.2008.04.171
   PubMed Web of Science ®Google Scholar
• Keitel V, Reinehr R, Gatsios P, Rupprecht C, Görg B, Selbach O, Haussinger D, Kubitz R. 2007. The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology. 45:695–704.10.1002/hep.21458
   PubMed Web of Science ®Google Scholar
• Kohli R, Bradley D, Setchell KD, Eagon JC, Abumrad N, Klein S. 2013. Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab. 98:E708–712.10.1210/jc.2012-3736
   PubMed Web of Science ®Google Scholar
• Lambert G, Amar MJ, Guo G, Brewer Jr HB, Gonzalez FJ, Sinal CJ. 2003. The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J Biol Chem. 278:2563–2570.10.1074/jbc.M209525200
   PubMed Web of Science ®Google Scholar
• Lee H, Zhang Y, Lee FY, Nelson SF, Gonzalez FJ, Edwards PA. 2006. FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine. J Lipid Res. 47:201–214.10.1194/jlr.M500417-JLR200
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JY. 2013. Nuclear receptors in bile acid metabolism. Drug Metab Rev. 45:145–155.10.3109/03602532.2012.740048
   PubMed Web of Science ®Google Scholar
• Li-Hawkins J, Gafvels M, Olin M, Lund EG, Andersson U, Schuster G, Bjorkhem I, Russell DW, Eggertsen G. 2002. Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. J Clin Invest. 110:1191–1200.10.1172/JCI0216309
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhou Y, Wang Y, Geng D, Liu J. 2011. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1. Obes Surg. 21:1424–1431.10.1007/s11695-011-0388-z
   PubMed Web of Science ®Google Scholar
• Lou G, Ma X, Fu X, Meng Z, Zhang W, Wang Y-D, Van Ness C, Yu D, Xu R, Huang W, Bursill C. 2014. GPBAR1/TGR5 mediates bile acid-induced cytokine expression in murine Kupffer cells. PloS One. 9:e93567.10.1371/journal.pone.0093567.s006
   PubMed Web of Science ®Google Scholar
• Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ. 2000. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell. 6:507–515.10.1016/S1097-2765(00)00050-2
   PubMed Web of Science ®Google Scholar
• Ma K, Saha PK, Chan L, Moore DD. 2006. Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest. 116:1102–1109.10.1172/JCI25604
   PubMed Web of Science ®Google Scholar
• Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B. 1999. Identification of a nuclear receptor for bile acids. Science. 284:1362–1365.10.1126/science.284.5418.1362
   PubMed Web of Science ®Google Scholar
• Modica S, Gofflot F, Murzilli S, D'Orazio A, Salvatore L, Pellegrini F, Nicolucci A, Tognoni G, Copetti M, Valanzano R, et al. 2010. The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors. Gastroenterology. 138:636–648, e12.10.1053/j.gastro.2009.09.060
   PubMed Web of Science ®Google Scholar
• Modica S, Murzilli S, Salvatore L, Schmidt DR, Moschetta A. 2008. Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res. 68:9589–9594.10.1158/0008-5472.CAN-08-1791
   PubMed Web of Science ®Google Scholar
• Perino A, Pols TW, Nomura M, Stein S, Pellicciari R, Schoonjans K. 2014. TGR5 reduces macrophage migration through mTOR-induced C/EBPbeta differential translation. J Clin Invest. pii:76289. [Epub ahead of print]
   Google Scholar
• Popescu IR, Helleboid-Chapman A, Lucas A, Vandewalle B, Dumont J, Bouchaert E, Derudas B, Kerr-Conte J, Caron S, Pattou F, et al. 2010. The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity. FEBS Lett. 584:2845–2851.10.1016/j.febslet.2010.04.068
   PubMed Web of Science ®Google Scholar
• Rabiee A, Magruder JT, Salas-Carrillo R, Carlson O, Egan JM, Askin FB, Elahi D, Andersen DK. 2011. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. J Surg Res. 167:199–205.10.1016/j.jss.2010.09.047
   PubMed Web of Science ®Google Scholar
• Renga B, Mencarelli A, Vavassori P, Brancaleone V, Fiorucci S. 2010. The bile acid sensor FXR regulates insulin transcription and secretion. Biochim Biophys Acta. 1802:363–372.10.1016/j.bbadis.2010.01.002
   PubMed Web of Science ®Google Scholar
• Russell DW. 2003. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 72:137–174.10.1146/annurev.biochem.72.121801.161712
   PubMed Web of Science ®Google Scholar
• Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R, Wilson-Perez HE, Sandoval DA, Kohli R, Backhed F, et al. 2014. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 509:183–188.10.1038/nature13135
   PubMed Web of Science ®Google Scholar
• Song KH, Li T, Owsley E, Strom S, Chiang JY. 2009. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology. 49:297–305.10.1002/hep.22627
   PubMed Web of Science ®Google Scholar
• Stayrook KR, Bramlett KS, Savkur RS, Ficorilli J, Cook T, Christe ME, Michael LF, Burris TP. 2005. Regulation of carbohydrate metabolism by the farnesoid X receptor. Endocrinology. 146:984–991.10.1210/en.2004-0965
   PubMed Web of Science ®Google Scholar
• Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, Macchiarulo A, Yamamoto H, Mataki C, Pruzanski M, et al. 2009. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 10:167–177.10.1016/j.cmet.2009.08.001
   PubMed Web of Science ®Google Scholar
• Wang L, Lee YK, Bundman D, Han Y, Thevananther S, Kim CS, Chua SS, Wei P, Heyman RA, Karin M, et al. 2002. Redundant pathways for negative feedback regulation of bile acid production. Dev Cell. 2:721–731.10.1016/S1534-5807(02)00187-9
   PubMed Web of Science ®Google Scholar
• Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, Harney JW, Ezaki O, Kodama T, et al. 2006. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 439:484–489.10.1038/nature04330
   PubMed Web of Science ®Google Scholar
• Watanabe M, Morimoto K, Houten SM, Kaneko-Iwasaki N, Sugizaki T, Horai Y, Mataki C, Sato H, Murahashi K, Arita E, et al. 2012. Bile acid binding resin improves metabolic control through the induction of energy expenditure. PloS One. 7:e38286.10.1371/journal.pone.0038286.s003
   PubMed Web of Science ®Google Scholar
• Zhang X, Huang S, Gao M, Liu J, Jia X, Han Q, Zheng S, Miao Y, Li S, Weng H, et al. 2014. Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice. Proc Natl Acad Sci USA. 111:2277–2282.10.1073/pnas.1323977111
   PubMed Web of Science ®Google Scholar
• Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, Edwards PA. 2004. Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev. 18:157–169.10.1101/gad.1138104
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lee FY, Barrera G, Lee H, Vales C, Gonzalez FJ, Willson TM, Edwards PA. 2006. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Natl Acad Sci USA. 103:1006–1011.10.1073/pnas.0506982103
   PubMed Web of Science ®Google Scholar